[{"address1": "One Amgen Center Drive", "city": "Thousand Oaks", "state": "CA", "zip": "91320-1799", "country": "United States", "phone": "805 447 1000", "fax": "805 447 1010", "website": "https://www.amgen.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh\u00e7et's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 28000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert A. Bradway", "age": 61, "title": "Chairman, CEO & President", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 6731433, "exercisedValue": 0, "unexercisedValue": 64735872}, {"maxAge": 1, "name": "Mr. Peter H. Griffith", "age": 65, "title": "Executive VP & CFO", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 3069385, "exercisedValue": 0, "unexercisedValue": 1429055}, {"maxAge": 1, "name": "Mr. Esteban  Santos", "age": 56, "title": "Executive Vice President of Operations", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 3006074, "exercisedValue": 0, "unexercisedValue": 12988893}, {"maxAge": 1, "name": "Dr. David M. Reese M.D.", "age": 61, "title": "Executive VP & CTO", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 3402742, "exercisedValue": 0, "unexercisedValue": 9008793}, {"maxAge": 1, "name": "Mr. Murdo  Gordon", "age": 57, "title": "Executive Vice President of Global Commercial Operations", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 3243134, "exercisedValue": 0, "unexercisedValue": 5928890}, {"maxAge": 1, "name": "Mr. Matthew C. Busch", "age": 49, "title": "Chief Accounting Officer & VP of Finance", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Skellenger", "title": "Senior VP & Chief Information Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Howard Y. Chang M.D., Ph.D.", "title": "Senior VP of Global Research & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Justin G. Claeys", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan P. Graham J.D.", "age": 63, "title": "Executive VP, General Counsel & Secretary", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 2440307, "exercisedValue": 0, "unexercisedValue": 2105468}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 2, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 312.64, "open": 312.23, "dayLow": 310.3, "dayHigh": 314.5069, "regularMarketPreviousClose": 312.64, "regularMarketOpen": 312.23, "regularMarketDayLow": 310.3, "regularMarketDayHigh": 314.5069, "dividendRate": 9.52, "dividendYield": 3.03, "exDividendDate": 1747353600, "payoutRatio": 1.1905, "fiveYearAvgDividendYield": 2.99, "beta": 0.524, "trailingPE": 41.496033, "forwardPE": 15.177068, "volume": 2394865, "regularMarketVolume": 2394865, "averageVolume": 3328191, "averageVolume10days": 3128290, "averageDailyVolume10Day": 3128290, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 168526577664, "fiftyTwoWeekLow": 253.3, "fiftyTwoWeekHigh": 346.85, "priceToSalesTrailing12Months": 5.042083, "fiftyDayAverage": 290.8904, "twoHundredDayAverage": 306.2543, "trailingAnnualDividendRate": 9.0, "trailingAnnualDividendYield": 0.028787103, "currency": "USD", "tradeable": false, "enterpriseValue": 217432555520, "profitMargins": 0.122370005, "floatShares": 535636305, "sharesOutstanding": 537204992, "sharesShort": 16158990, "sharesShortPriorMonth": 12741466, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0301, "heldPercentInsiders": 0.00219, "heldPercentInstitutions": 0.82018995, "shortRatio": 5.0, "shortPercentOfFloat": 0.0301, "impliedSharesOutstanding": 537204992, "bookValue": 10.946, "priceToBook": 28.659782, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": -0.183, "netIncomeToCommon": 4089999872, "trailingEps": 7.56, "forwardEps": 20.67, "lastSplitFactor": "2:1", "lastSplitDate": 943228800, "enterpriseToRevenue": 6.505, "enterpriseToEbitda": 14.345, "52WeekChange": 0.15802884, "SandP52WeekChange": 0.09506309, "lastDividendValue": 2.38, "lastDividendDate": 1739491200, "quoteType": "EQUITY", "currentPrice": 313.71, "targetHighPrice": 389.0, "targetLowPrice": 185.0, "targetMeanPrice": 315.94885, "targetMedianPrice": 324.0, "recommendationMean": 2.41935, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 11973000192, "totalCashPerShare": 22.288, "ebitda": 15157000192, "totalDebt": 60878999552, "quickRatio": 0.843, "currentRatio": 1.257, "totalRevenue": 33423998976, "debtToEquity": 1035.886, "revenuePerShare": 62.242, "returnOnAssets": 0.064, "returnOnEquity": 0.67553, "grossProfits": 22965999616, "freeCashflow": 13725875200, "operatingCashflow": 11489999872, "earningsGrowth": -0.187, "revenueGrowth": 0.109, "grossMargins": 0.68711, "ebitdaMargins": 0.45348, "operatingMargins": 0.51805, "financialCurrency": "USD", "symbol": "AMGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_24816", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Amgen Inc.", "longName": "Amgen Inc.", "corporateActions": [], "postMarketTime": 1741996655, "regularMarketTime": 1741982401, "regularMarketChangePercent": 0.34223923, "regularMarketPrice": 313.71, "marketState": "CLOSED", "postMarketChangePercent": -0.162564, "postMarketPrice": 313.2, "postMarketChange": -0.509979, "regularMarketChange": 1.0699768, "regularMarketDayRange": "310.3 - 314.5069", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3328191, "fiftyTwoWeekLowChange": 60.40999, "fiftyTwoWeekLowChangePercent": 0.23849186, "fiftyTwoWeekRange": "253.3 - 346.85", "fiftyTwoWeekHighChange": -33.140015, "fiftyTwoWeekHighChangePercent": -0.095545664, "fiftyTwoWeekChangePercent": 15.802884, "dividendDate": 1749168000, "earningsTimestamp": 1738702868, "earningsTimestampStart": 1746010740, "earningsTimestampEnd": 1746446400, "earningsCallTimestampStart": 1738704600, "earningsCallTimestampEnd": 1738704600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 7.56, "epsForward": 20.67, "epsCurrentYear": 20.63811, "priceEpsCurrentYear": 15.20052, "fiftyDayAverageChange": 22.81958, "fiftyDayAverageChangePercent": 0.07844734, "twoHundredDayAverageChange": 7.4556885, "twoHundredDayAverageChangePercent": 0.024344763, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 424704600000, "displayName": "Amgen", "trailingPegRatio": 1.0651, "__fetch_time": "2025-03-15"}]